DrugPatentWatch Database Preview
Drugs in Development Information for AZD3293
Join the DrugPatentWatch Referral Program Get access to a free drug patent landscape report or a free one-month subscription
What is the development status for investigational drug AZD3293?
AZD3293 is an investigational drug.
There have been 15 clinical trials for AZD3293.
The most recent clinical trial was a Phase 1 trial, which was initiated on March 1st 2017.
The most common disease conditions in clinical trials are Alzheimer Disease, Dementia, and [disabled in preview]. The leading clinical trial sponsors are AstraZeneca, Eli Lilly and Company, and Parexel.
There are five US patents protecting this investigational drug and sixty-two international patents.
Summary for AZD3293
| US Patents | 5 |
| International Patents | 62 |
| US Patent Applications | 8 |
| WIPO Patent Applications | 1 |
| Japanese Patent Applications | 0 |
| Clinical Trial Progress | Phase 1 (2017-03-01) |
| Vendors | 16 |
Recent Clinical Trials for AZD3293
| Title | Sponsor | Phase |
|---|---|---|
| A Study of LY3314814 in Early Alzheimer's Disease Dementia | AstraZeneca | Phase 3 |
| A Study of LY3314814 in Early Alzheimer's Disease Dementia | Eli Lilly and Company | Phase 3 |
| A Study of LY3314814 in Healthy Participants When Taken With Rosuvastatin | AstraZeneca | Phase 1 |
Clinical Trial Summary for AZD3293
Top disease conditions for AZD3293
Top clinical trial sponsors for AZD3293
US Patents for AZD3293
| Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
|---|---|---|---|---|
| AZD3293 | Start Trial | Compounds and their use as BACE inhibitors | AstraZeneca AB (Sodertalje, SE) | Start Trial |
| AZD3293 | Start Trial | Compounds and their use as BACE inhibitors | AstraZeneca AB (Sodertalje, SE) | Start Trial |
| AZD3293 | Start Trial | Compounds and their use as BACE inhibitors | Astrazeneca AB (Sodertalje, SE) | Start Trial |
| AZD3293 | Start Trial | Compounds and their use as BACE inhibitors | ASTRAZENECA AB (Sodertalje, SE) | Start Trial |
| AZD3293 | Start Trial | Compounds and their use as BACE inhibitors | ASTRAZENECA AB (Sodertalje, SE) | Start Trial |
| >Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |
International Patents for AZD3293
| Drugname | Country | Document Number | Estimated Expiration | Related US Patent |
|---|---|---|---|---|
| AZD3293 | Argentina | 084553 | 2030-12-22 | Start Trial |
| AZD3293 | Argentina | 107709 | 2030-12-22 | Start Trial |
| AZD3293 | Australia | 2011345389 | 2030-12-22 | Start Trial |
| AZD3293 | Australia | 2016200538 | 2030-12-22 | Start Trial |
| AZD3293 | Australia | 2017261475 | 2030-12-22 | Start Trial |
| AZD3293 | Brazil | 112013016030 | 2030-12-22 | Start Trial |
| >Drugname | >Country | >Document Number | >Estimated Expiration | >Related US Patent |
